Application of deep learning-clinical baseline feature fusion model to predict postoperative mortality in elderly patients with hip fracture: a multicenter study

应用深度学习-临床基线特征融合模型预测老年髋部骨折患者术后死亡率:一项多中心研究

阅读:1

Abstract

BACKGROUND: A large number of studies have focused on building different models to predict postoperative mortality in elderly patients with hip fractures, including sarcopenia risk factor models or deep learning models. However, relying on deep learning models alone may not fully capture the key factors that affect patient outcomes, so it may be a more accurate model to construct predictive models combining clinical baseline features. METHODS: A deep learning model (Densenet161) and a deep learning-clinical baseline feature fusion model (LightGBM) were constructed using 221 patients from Institution 1 as the internal training set and 113 from Institution 2 as the external validation set, respectively. We selected the skeletal muscle tissue image of the 12th thoracic vertebral cross section in the chest CT (computerized tomography) scan as the input data of the Densenet161 model. The model's predictive performance was evaluated using AUC (area under the curve), sensitivity, specificity, and F1 scores. RESULTS: The Densenet161 model has an average performance in predicting 1-year postoperative mortality in elderly patients with hip fractures, with an AUC of 0.723 and an F1 score of 0.421 on the external validation set. Compared with Densenet161 model, the predictive performance of LightGBM fusion model has been greatly improved, with AUC of 0.815 and F1 score of 0.819 on the external validation set. CONCLUSION: Combining the image features extracted by the deep learning model with the patient's clinical baseline characteristics, the LightGBM fusion model can better predict the 1-year mortality of elderly hip fracture patients than relying on a single deep learning model.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。